EKF Diagnostics Holdings ( (GB:EKF) ) has provided an update.
EKF Diagnostics Holdings plc has published its Annual Report and Accounts for the year ending December 31, 2024, along with the notice for its 2025 Annual General Meeting (AGM). The AGM is scheduled for May 20, 2025, in London, with provisions for shareholders to participate online or via phone. The company encourages shareholders to vote online and submit questions in advance, streamlining the process for engagement and decision-making.
More about EKF Diagnostics Holdings
EKF Diagnostics Holdings plc is an AIM-listed global diagnostics business specializing in point-of-care analyzers for hematology and diabetes, as well as life sciences services, including the manufacture of enzymes and custom products for diagnostic, food, and industrial applications. The company is headquartered in Penarth, near Cardiff, and operates five manufacturing sites across the US and Germany, selling products in over 120 countries worldwide.
YTD Price Performance: -22.22%
Average Trading Volume: 568,192
Technical Sentiment Signal: Buy
Current Market Cap: £94.82M
For an in-depth examination of EKF stock, go to TipRanks’ Stock Analysis page.